---

Design, molecular docking studies and ADME prediction of 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives as CYP51 inhibitor for antimicrobial activity

---

Original Article

Author Details : Pooja Subhash Jadhav*, Dipali Pandharinath Gadekar, Prerana B. Jadhav, Shailaja B. Jadhav

Volume : 4, Issue : 2, Year : 2022

Article Page : 83-89

https://doi.org/10.18231/j.ctppc.2022.015

Suggest article by email

Get Permission

---

Abstract

The 1, 3, 4-Oxadiazole nucleus offers a wide range of applications in hetero cyclic chemistry, including antimicrobial medicine. A series of the 2, 5-disubstituted 1, 3, 4-Oxadiazole derivatives were designed and study was performed against the ergosterol biosynthesis as an antimicrobial target. The drug-likeness properties of the designed compounds were predicted. All the designed compounds showed good ADME properties and investigated for CYP51 inhibitory activity. According to molecular docking studies, all compounds showed better interaction with target protein and could be the potent inhibitor of ergosterol biosynthesis. The designed 2, 5-disubstituted 1, 3, 4-Oxadiazole derivatives analogs could be safer and more or equivalent effective antimicrobial agents.

Keywords: Antimicrobial, CYP51 inhibitor, In silico, ADME, Molecular Docking

How to cite : Jadhav P S, Gadekar D P, Jadhav P B, Jadhav S B, Design, molecular docking studies and ADME prediction of 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives as CYP51 inhibitor for antimicrobial activity. Curr Trends Pharm Pharm Chem 2022;4(2):83-89

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.